Determination of Enantiomeric Excess via 31P-NMR

IF 2.8 4区 化学 Q2 CHEMISTRY, ANALYTICAL
Chirality Pub Date : 2025-04-01 DOI:10.1002/chir.70032
Ellis Guernsey, Jean-Luc Montchamp
{"title":"Determination of Enantiomeric Excess via 31P-NMR","authors":"Ellis Guernsey,&nbsp;Jean-Luc Montchamp","doi":"10.1002/chir.70032","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p><sup>31</sup>P is a very attractive nucleus for nuclear magnetic resonance (NMR) analysis because of the large chemical dispersion and the simplicity of the spectra when compared with other nuclei (other than <sup>19</sup>F). The ability to rapidly and quantitatively assay for enantiomeric excess (ee) measurements of alcohols, amines, thiols, and other chiral species using <sup>31</sup>P-NMR is essential. Analysis of ee is particularly important in the pharmaceutical industry because a majority of medicinal compounds contain chiral centers, and enantiomers may possess different pharmacological activities. Although high-performance liquid chromatography (HPLC) with chiral stationary phase has become the standard method for ee determination, it can often be expensive and time consuming and requires purified samples. <sup>31</sup>P-NMR offers advantages over many other nuclei as the interpretation is rapid and can have large chemical shift differences (Δ<i>δ</i>) when comparing diastereomers. Proton decoupling avoids overlapping signals by preventing proton coupling, which could result in overlapping signals. With the rapid growth of asymmetric organocatalysis and asymmetric synthesis, the ability to quickly determine ee via phosphorus containing chiral derivatizing agents (CDAs) and chiral solvating agents (CSAs) is of utmost utility. It might be especially useful if used to determine ee directly in a reaction mixture, thereby alleviating any need for purification. This review focuses on ee determination by <sup>31</sup>P-NMR.</p>\n </div>","PeriodicalId":10170,"journal":{"name":"Chirality","volume":"37 4","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chirality","FirstCategoryId":"92","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/chir.70032","RegionNum":4,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0

Abstract

31P is a very attractive nucleus for nuclear magnetic resonance (NMR) analysis because of the large chemical dispersion and the simplicity of the spectra when compared with other nuclei (other than 19F). The ability to rapidly and quantitatively assay for enantiomeric excess (ee) measurements of alcohols, amines, thiols, and other chiral species using 31P-NMR is essential. Analysis of ee is particularly important in the pharmaceutical industry because a majority of medicinal compounds contain chiral centers, and enantiomers may possess different pharmacological activities. Although high-performance liquid chromatography (HPLC) with chiral stationary phase has become the standard method for ee determination, it can often be expensive and time consuming and requires purified samples. 31P-NMR offers advantages over many other nuclei as the interpretation is rapid and can have large chemical shift differences (Δδ) when comparing diastereomers. Proton decoupling avoids overlapping signals by preventing proton coupling, which could result in overlapping signals. With the rapid growth of asymmetric organocatalysis and asymmetric synthesis, the ability to quickly determine ee via phosphorus containing chiral derivatizing agents (CDAs) and chiral solvating agents (CSAs) is of utmost utility. It might be especially useful if used to determine ee directly in a reaction mixture, thereby alleviating any need for purification. This review focuses on ee determination by 31P-NMR.

求助全文
约1分钟内获得全文 求助全文
来源期刊
Chirality
Chirality 医学-分析化学
CiteScore
4.40
自引率
5.00%
发文量
124
审稿时长
1 months
期刊介绍: The main aim of the journal is to publish original contributions of scientific work on the role of chirality in chemistry and biochemistry in respect to biological, chemical, materials, pharmacological, spectroscopic and physical properties. Papers on the chemistry (physiochemical, preparative synthetic, and analytical), physics, pharmacology, clinical pharmacology, toxicology, and other biological aspects of chiral molecules will be published.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信